Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor.

Ken-ichi Hiasa; Kensuke Egashira; Shiro Kitamoto; Minako Ishibashi; Shujiro Inoue; Weihua Ni; Qingwei Zhao; Shin Nagata; Makoto Katoh; Masataka Sata

doi:10.1007/s00395-004-0456-9

Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor.

Identifier:nobleid.org/w1/20260515/CB2C8F2B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB2C8F2B.svg?ark=w1%2F20260515%2FCB2C8F2B)](https://nobleid.org/work/w1/20260515/CB2C8F2B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor.

Identifier:nobleid.org/w1/20260515/CB2C8F2B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB2C8F2B.svg?ark=w1%2F20260515%2FCB2C8F2B)](https://nobleid.org/work/w1/20260515/CB2C8F2B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work